Profile: Evocutis PLC (EVO.L)

EVO.L on London Stock Exchange

0.25GBp
24 Apr 2015
Change (% chg)

0.05p (+24.39%)
Prev Close
0.20p
Open
0.20p
Day's High
--
Day's Low
--
Volume
14,914,838
Avg. Vol
5,726,327
52-wk High
1.30p
52-wk Low
0.16p

Search Stocks
Evocutis plc is engaged in providing skin microbiology and clinical dermatology services to companies in pharmaceutical and consumer healthcare markets, using the Company’s living skin technology, LabSkin. The Company provides independent research and testing facilities specializing in skin microbiology, living skin tissue culture and clinical dermatology. The Company’s business areas are collaboration studies utilizing LabSkin and microbiology along with clinical evaluation studies. It is also engaged in the commercialization of licensing opportunities for its compounds, principally SYN1113.

Company Address

Evocutis PLC

24 Cornhill
LONDON     EC3V 3ND
P: +44845.2008341

Company Web Links

Search Stocks